Login Sign up free
Home Stock ScreenerScreener ETF ScreenerETF Maps Charts News Groups Insider Futures Forex Crypto Watchlist Portfolio Calendar
Pricing
Black Friday Get Elite for just $149.00 Claim Now
Market News Market Pulse Stocks News ETF News Crypto News

Bioventus, Inc.

Contributing Author

Recent Articles by Bioventus, Inc.

Nov-02
Bioventus Reports Third Quarter Financial Results BVS BVS -16.77% GlobeNewswire
Oct-27
Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026 BVS GlobeNewswire
Aug-05
Bioventus Reports Second Quarter Financial Results BVS +13.71% GlobeNewswire
Jul-29
Bioventus to Report Second Quarter of Fiscal Year 2026 Financial Results on August 5, 2026 BVS GlobeNewswire
Jun-02
Bioventus to Present at the Goldman Sachs 47TH Annual Global Healthcare Conference BVS GlobeNewswire
May-06
Bioventus Reports First Quarter Financial Results BVS GlobeNewswire
Apr-28
Bioventus to Report First Quarter of Fiscal Year 2026 Financial Results on May 6, 2026 BVS GlobeNewswire
Mar-05
Bioventus Announces Fourth Quarter and Full Year 2025 Financial Results BVS +7.44% GlobeNewswire
Feb-24
Bioventus to Report Fourth Quarter of Fiscal Year 2025 Financial Results on March 5, 2026 BVS GlobeNewswire
Jan-06
Bioventus to Present at the 44th Annual J.P. Morgan Healthcare Conference BVS GlobeNewswire
Nov-25
Bioventus to Present at the Piper Sandler 37th Annual Healthcare Conference BVS +5.13% GlobeNewswire
Nov-04
Bioventus Reports Third Quarter Financial Results BVS +15.09% GlobeNewswire
Oct-28
Bioventus to Report Third Quarter of Fiscal Year 2025 Financial Results on November 4, 2025 BVS GlobeNewswire
Sep-03
Bioventus to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference BVS GlobeNewswire
Aug-07
Bioventus to Present at the Canaccord Genuity 45th Annual Global Growth Conference BVS GlobeNewswire
Aug-06
Bioventus Reports Second Quarter Financial Results BVS +18.73% GlobeNewswire
Aug-04
Bioventus Enters into a New $400 Million Senior Secured Credit Agreement Lowering Interest Expense and Providing Increased Liquidity BVS GlobeNewswire
Jul-30
Bioventus Receives FDA 510(k) Clearances for two Next-Generation Peripheral Nerve Stimulation Products BVS GlobeNewswire
Jul-29
Bioventus to Report Second Quarter of Fiscal Year 2025 Financial Results on August 6, 2025 BVS GlobeNewswire
May-06
Bioventus Reports First Quarter Financial Results BVS -11.81% GlobeNewswire
Affiliate • Advertise • APIs • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information
Stock quotes delayed by 1 minute. Futures and options delayed by 15 minutes.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)